C6F-97023-26830
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 760 / TX
- Registered
- 2021-11-05
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-09-13
Dose 1 — Pfizer-BioNTech
-
2021-10-04
Dose 2 — Pfizer-BioNTech
-
2021-11-05
Registered in v-safe
- 2021-11-05
-
2021-11-08
Survey response — day 35, dose 2MedDRA: Chills, Nasal congestion, Pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Runny/stuffy nose, chills/achesMedDRA releases: 2024-11 · check-in free text available
- 2021-11-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-13 | Pfizer-BioNTech | No |
| 2 | 2021-10-04 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 2
Symptoms: Runny/stuffy nose, chills/aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release